Amyloid Center

Amyloid Solutions is a South Korean biotechnology company dedicated to developing disease-modifying therapies for neurodegenerative disorders, with a primary focus on Alzheimer's disease. The company utilizes a proprietary platform to identify and develop small molecules and monoclonal antibodies that target toxic protein aggregates such as amyloid-beta and tau. Their pipeline includes several early-stage programs aimed at preventing or reversing the progression of dementia and other protein-misfolding diseases. By leveraging deep expertise in amyloid biology, Amyloid Solutions seeks to address the significant unmet medical needs in the aging global population.